1. Home
  2. RXRX vs ICHR Comparison

RXRX vs ICHR Comparison

Compare RXRX & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Recursion Pharmaceuticals Inc.

RXRX

Recursion Pharmaceuticals Inc.

HOLD

Current Price

$2.98

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$85.73

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RXRX
ICHR
Founded
2013
1999
Country
United States
United States
Employees
N/A
2448
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
3.0B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
RXRX
ICHR
Price
$2.98
$85.73
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$7.50
$49.50
AVG Volume (30 Days)
23.4M
1.2M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
14.79
N/A
EPS
N/A
N/A
Revenue
$74,681,000.00
$947,652,000.00
Revenue This Year
$12.11
$20.51
Revenue Next Year
$82.52
$17.08
P/E Ratio
N/A
N/A
Revenue Growth
26.92
11.61
52 Week Low
$2.77
$13.15
52 Week High
$7.18
$113.58

Technical Indicators

Market Signals
Indicator
RXRX
ICHR
Relative Strength Index (RSI) 39.18 47.17
Support Level $2.88 $79.47
Resistance Level $4.03 $113.58
Average True Range (ATR) 0.19 7.55
MACD -0.06 -1.18
Stochastic Oscillator 10.74 38.18

Price Performance

Historical Comparison
RXRX
ICHR

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

About ICHR Ichor Holdings

Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.

Share on Social Networks: